This study is in progress, not accepting new patients
A Study of Capmatinib in Lung Cancer Patients
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages 18-90 (full criteria)
- Location
- at UC Davis UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Amy Cummings (ucla)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Amy Cummings (ucla)
HS Assistant Clinical Professor, Medicine. Authored (or co-authored) 18 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT04926831
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 4 people participating
- Last Updated